UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended ~~October~~January 31, ~~2025~~2026

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 000-54851

DEFENSE TECHNOLOGIES INTERNATIONAL CORP.

(Exact name of registrant as specified in its charter)

Delaware		99-0363802
(State of Incorporation)		(I.R.S. Employer Identification Number)

2683 ~~Via~~Vía De La Valle, Suite G418, Del Mar CA 92014

(Address of principal executive offices)

(800) 520-9485

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging Growth Company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~February~~ 9April 23, 2026, there were 37,531,767 shares of the registrant’s common stock, 2,535,135 Series A preferred and 1,200,254 Series B preferred and 531 Series D preferred: $0.0001 par value, outstanding.

DEFENSE TECHNOLOGIES INTERNATIONAL CORP.

FORM 10-Q

FOR THE ~~THREE AND SIX~~NINE-MONTH PERIODS ENDED ~~OCTOBER~~ JANUARY 31, ~~2025~~2026 AND ~~2024~~2025

TABLE OF CONTENTS

	PART I — FINANCIAL INFORMATION	Page
		Page
Item 1.	Financial Statements:	3
PART I — FINANCIAL INFORMATION
	Condensed Consolidated Balance Sheets as of October 31, 2025 (Unaudited) and April 30, 2025 (Audited)	3
Item 1.	Financial Statements:	3
	Condensed Consolidated Statements of Operations for the Three and Six Month Periods Ended October 31, 2025 and 2024 (Unaudited)	4
	Condensed Consolidated Balance Sheets as of January 31, 2026 (Unaudited) and April 30, 2025 (Audited)	3
	Condensed Consolidated Statements of Stockholders’ Deficit for the Six Months Ended October 31, 2025 and 2024 (Unaudited)	5
	Condensed Consolidated Statements of Operations for the Three and Nine Month Periods Ended January 31, 2026 and 2025 (Unaudited)	4
	Condensed Consolidated Statements of Cash Flows for the Six Month Periods Ended October 31, 2025 and 2024 (Unaudited)	6
	Condensed Consolidated Statements of Shareholders Deficit for the Nine Months Ended January 31, 2026 and 2025(Unaudited)	5
	Notes to Condensed Consolidated Financial Statements	7
	Condensed Consolidated Statements of Cash Flows for the Nine Month Periods Ended January 31, 2026 and 2025 (Unaudited)	6
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	14
	Notes to Condensed Consolidated Financial Statements	7
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	16
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16
Item 4.	Controls and Procedures	16
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	18
	PART II — OTHER INFORMATION
Item 4.	Controls and Procedures	18
Item 1.	Legal Proceedings	17
PART II — OTHER INFORMATION
Item 1A.	Risk Factors	17
Item 1.	Legal Proceedings	19
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds.	17
Item 1A.	Risk Factors	19
Item 3.	Defaults upon Senior Securities	17
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds.	19
Item 4.	Mine Safety Disclosure	17
Item 3.	Defaults upon Senior Securities	19
Item 5.	Other Information	17
Item 4.	Mine Safety Disclosure	19
Item 6.	Exhibits	18
Item 5.	Other Information	19
	Signatures	19
Item 6.	Exhibits	20
	Signatures	21

Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

Defense Technologies International Corp. and Subsidiary Condensed Consolidated Balance Sheets

Condensed Consolidated Balance Sheets

	January 31, 2026			April 30, 2025
	(Unaudited)			(Audited)
ASSETS
Current assets:
Cash	$	192		$	1,493
Inventory		7,599			7,599
Total current assets		7,791			9,092

Total assets	$	7,791		$	9,092

Current liabilities:
Accounts payable and accrued expense	$	216,670		$	172,082
Accrued licenses agreement payable		62,500			25,000
Accrued interest and fees payable		261,541			220,521
Convertible notes payable, net of discount		215,392			185,762
Derivative liabilities		68,645			31,866
Payables – related parties		1,014,693			747,208
Customer deposits		40,375			40,375
Stock payable		24,000			24,000
Notes payable		565,288			476,312
Note payable- related party		199,844			161,092
Total current liabilities		2,668,948			2,084,218

Total liabilities	$	2,668,948		$	2,084,218

Commitments and Contingencies		-			-

Stockholders’ deficit:
Preferred stock, $0.0001 par value; 20,000,000 shares authorized, Series A – 2,535,135 and 2,535,135 shares issued and outstanding, respectively		253			253
Series B –1,200,254 and 1,100,254 shares issued and outstanding, respectively		120			110
Series D – 531 and 560 shares issued and outstanding, respectively		-			-

Common stock, $0.0001 par value; 600,000,000 shares authorized, 35,531,767 and 34,147,881 shares issued and outstanding, respectively		3,754			3,416
Additional paid-in capital		16,359,889			16,324,169
Accumulated deficit		(18,628,736	)		(18,042,197	)
Total		(2,264,720	)		(1,714,249	)
Non-controlling interest		(396,437	)		(360,877	)
Total stockholders’ deficit		(2,661,157	)		(2,075,126	)

Total liabilities and stockholders’ deficit	$	7,791		$	9,092

	October 31, 2025			April 30, 2025
	(Unaudited)			(Audited)
ASSETS
Current assets:
Cash	$	63		$	1,493
Inventory		7,599			7,599
Total current assets		7,662			9,092
Total assets	$	7,662		$	9,092
Current liabilities:
Accounts payable and accrued expense	$	197,596		$	172,082
Accrued licenses agreement payable		50,000			25,000
Accrued interest and fees payable		233,491			220,521
Convertible notes payable, net of discount		215,392			185,762
Derivative liabilities		53,333			31,866
Payables – related parties		937,877			747,208
Customer deposits		40,375			40,375
Stock payable		24,000			24,000
Notes payable		541,288			476,312
Note payable- related party		183,662			161,092
Total current liabilities		2,477,014			2,084,218
Total liabilities	$	2,477,014		$	2,084,218
Commitments and Contingencies		-			-
Stockholders’ deficit:
Preferred stock, $0.0001 par value; 20,000,000 shares authorized, Series A – 2,535,135 and 2,535,135 shares issued and outstanding, respectively		253			253
Series B –1,200,254 and 1,100,254 shares issued and outstanding, respectively		120			110
Series D – 531 and 600 shares issued and outstanding, respectively		-			-
Common stock, $0.0001 par value; 600,000,000 shares authorized, 37,531,767 and 34,147,891 shares issued and outstanding, respectively		3,754			3,416
Additional paid-in capital		16,352,533			16,324,169
Accumulated deficit		(18,439,015	)		(18,042,197	)
Total		(2,082,355	)		(1,714,249	)
Non-controlling interest		(386,997	)		(360,877	)
Total stockholders’ deficit		(2,469,352	)		(2,075,126	)
Total liabilities and stockholders’ deficit	$	7,662		$	9,092

See notes to condensed consolidated financial statements

Table of Contents

Defense Technologies International Corp. and Subsidiary Condensed Consolidated Statements of Operations As of January 31, (Unaudited)

Condensed Consolidated Statements of Operations

	Three Months						Nine Months
	2026			2025			2026			2025
Expenses:
Consulting	$	75,250		$	93,200		$	255,250		$	429,992
General and administrative		68,503			223,603			217,914			421,758

Total expenses		143,753			316,803			473,164			851,750

Loss from operations		(143,753	)		(316,803	)		(473,164	)		(851,750	)

Other income (expense):
Gain (loss) on debt settlement		-			50,166			(1,500	)		773,231
Interest and other income (expense)		(28,740	)		(6,408	)		(42,058	)		(30,562	)
Gain (loss) on accounts payable		-			-			-			(250,000	)
Loss on Origination fee		(1,000	)					(43,529	)		-
Debt discount		(3,000	)		-			(3,000	)		-
Gain (loss) on derivative liability		(15,312	)		5,633			(36,779	)		13,090

Total other income (expense)		(48,052	)		49,391			(126,866	)		505,759

Income (loss) before income taxes		(191,805	)		(267,412	)		(600,030	)		(345,991	)

Provision for income taxes		-			-			-			-

Net income (loss) before non-controlling interest		(191,805	)		(267,412	)		(600,030	)		(345,991	)

Non- controlling interest in net income (loss) of the consolidated subsidiary		9,440			5,366			35,559			15,867

Net income (loss) attributed to the Company	$	(182,365	)	$	(262,046	)	$	(564,471	)	$	(330,124	)

Net income (loss) per common share: Basic and diluted	$	(0.00	)	$	(0.01	)	$	(0.00	)	$	(0.01	)
Weighted average common shares outstanding:
Basic and diluted		37,531,757			32,207,256			35,481,003			27,175,776

As of October 31,

(Unaudited)

	Three Months						Six Months
	2025			2024			2025			2024
Expenses:
Consulting	$	80,000		$	219,292		$	180,250		$	336,792
General and administrative		62,182			146,773			149,162			192,790
Total expenses		142,182			366,065			329,412			529,582
Loss from operations		(142,182	)		(366,065	)		(329,412	)		(529,582	)
Other income (expense):
Gain on debt settlement		-			723,065			-			723,065
Interest and other income (expense)		(6,253	)		(7,096	)		(13,318	)		(14,154	)
Gain (loss) on accounts payable		-			45,000						(250,000	)
Loss on origination fee		(5,000	)		-			(42,529	)		(5,000	)
Loss on notes		(1,500	)		-			(1,500	)		(5,000	)
Gain (loss) on derivative liability		(16,359	)		(709	)		(21,467	)		7,457
Total other income (expense)		(29,112	)		760,260			(78,814	)		456,368
Income (loss) before income taxes		(171,294	)		394,195			(408,226	)		(73,214	)
Provision for income taxes		-			-			-			-
Net income (loss) before non-controlling interest		(171,294	)		394,195			(408,226	)		(73,214	)
Non- controlling interest in net loss of the consolidated subsidiary		11,352			4,332			26,120			10,502
Net income (loss) attributed to the Company	$	(159,942	)	$	398,527		$	(382,106	)	$	(62,712	)
Net income (loss) per common share: Basic	$	(0.00	)	$	0.01		$	(0.00	)	$	(0.00	)
Net income(loss) per common share: Diluted	$	(0.00	)	$	0.01		$	(0.00	)	$	(0.00	)
Weighted average common shares outstanding: Basic		36,258,748			30,947,919			35,239,110			29,243,883
Weighted average common shares outstanding: Diluted		36,258,748			66,931,819			35,239,110			29,243,883

See notes to condensed consolidated financial statements

Table of Contents

Defense Technologies International Corp. and Subsidiary

Condensed Consolidated Statements of Stockholders’ Deficit

For the Three and ~~Six~~Nine Months Ended ~~October~~January 31, ~~2025~~2026 and ~~2024~~2025

(Unaudited)

	Preferred stock						Common Stock				Additional Paid-In			Accumulated			Non-Controlling			TotalStockholders’
											Additional						Non-			Total
	Preferred stock						Common Stock				Paid-In			Accumulated			Controlling			Stockholders’
	Shares			Amount			Shares		Amount		Capital			Deficit			Interest			Deficit
Balance at April 30, 2024		4,396,363		$	439			9,729,878	$	974	$	15,067,580		$	(17,116,309	)	$	(315,046	)	$	(2,362,362	)
Common stock issued for B preferred conversion		(1,068,686	)		(107	)		10,686,860		1,069		(962	)		-			-			-
Common stock issued for D preferred conversion		(7	)		-			431,181		43		(43	)					-			-
Common stock issued for accrued expense – RP		-			-			10,000,000		1,000		694,000			-			-			695,000
Common stock issued for services		-			-			100,000		10		9,990			-			-			10,000
Dividend on series D preferred		-			-			-		-		7,356			(7,356	)		-			-
Net loss		-			-			-		-		-			(461,239	)		(6,170	)		(467,409	)
Balance at July 31, 2024		3,327,664		$	332			30,947,919	$	3,096	$	15,777,921		$	(17,584,904	)	$	(321,216	)	$	(2,124,771	)
Series B shares issued for accrued expenses		191,314			19			-		-		789,312			-			-			789,332
Series B shares issued for accrued expenses-RP		79,991			8			-		-		329,922			-			-			329,930
Settlement on debt		-			-			-		-		(723,065	)		-			-			(723,065	)
Dividend on series D preferred		-			-			-		-		7,356			(7,356	)		-			-
Net income (loss)		-			-			-		-		-			398,527			(4,332	)		394,195
Balance at October 31, 2024		3,598,969		$	359		$	30,947,919	$	3,096	$	16,181,447		$	(17,193,733	)	$	(325,548	)	$	(1,334,379	)
Balance at April 30, 2025		3,635,950		$	363		$	34,147,881	$	3,416	$	16,324,169		$	(18,042,197	)	$	(360,877	)	$	(2,075,126	)
B series issued for accrued expense		22,000			3			-		-		54,496			-			-			54,499
Preferred Shares issued for debt conversion		100,000			10			-		-		12,490			-			-			12,500
B series issued for accrued expenses- RP		15,000			1			-		-		37,500			-			-			37,501
Common stock issued for service		-			-			750,000		75		44,929			-			-			45,000
Common stock issued for convertible notes		-			-			1,250,000		125		62,375			-			-			62,500
Common stock issued for D series conversion		-			-			1,199,962		120		(120	)		-			-			-
Debt settlement		-			-			-		-		(50,166	)		-			-			(50,166	)
Stock based compensation		-			-			-		-		(21,000	)		-			-			(21,000	)
Dividend on B series preferred		-			-			-		-		7,356			(7,356	)		-			-
Net loss		-			-			-		-		-			(267,412	)		(5,366	)		(272,778	)
Balance at January 31, 2025		3,635,969		$	363			34,147,881	$	3,416	$	16,316,813		$	(17,468,501	)	$	(330,914	)	$	(1,478,823	)
Balance at April 30, 2025		3,635,950		$	363			34,147,881	$	3,416	$	16,324,169		$	(18,042,197	)	$	(360,877	)	$	(2,075,126	)
Common stock issued for D preferred conversion		(14	)					1,628,667		163		(163	)		-			-			-
Preferred Shares issued for debt conversion		100,000			10			-		-		12,490			-			-			12,500
Dividend on series D preferred		-			-			-		-		7,356			(7,356	)		-			-
Net loss		-			-			-		-		-			(222,164	)		(14,768	)		(236,932	)
Balance at July 31, 2025		3,735,936		$	373		$	35,~~776~~775,558	$	3,579	$	16,343,852		$	(18,271,717	)	$	(375,645	)	$	(222,299,~~558~~588	)
Common stock for D series conversion		(15	)		-			1,755,209		175		(175	)		-			-			-
Loss on notes		-			-			-		-		1,500			-			-			1,500
Dividend on D series preferred		-			-			-		-		7,356			(7,~~356~~335	)		-			-
Net loss		-			-			-		-		-			(159,942	)		(11,352	)		(171,294	)
Balance at October 31, 2025		3,735,921		$	373			37,531,767	$	3,754	$	16,352,533		$	(18,439,015	)	$	(386,997	)	$	(2,469,352	)
Deemed dividend		-			-			-		-		7,356			(7,356	)		-			-
Net loss		-			-			-		-		-			(182,365	)		(9,440	)		(191,805	)
Balance at January 31, 2026		3,735,935		$	373			37,531,767	$	3,754	$	16,359,889		$	(18,628,736	)	$	(396,437	)	$	(2,661,157	)

See notes to condensed consolidated financial statements

Table of Contents

Defense Technologies International Corp and Subsidiaries Condensed Consolidated Statements of Cash Flows (Unaudited)

Condensed Consolidated Statements of Cash Flows

	Nine Months Ended January 31,
	2026			2025
Cash flows from operating activities:
Net loss	$	(600,030	)	$	(345,991	)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Common stock issued for service		-			58,000
(Gain) loss on derivative liability		36,779			(13,090	)
Loss on debt settlement		1,500			-
Loss on notes		29,630			-
Debt discount		-			9,677
Loan origination fee		10,900			-
Gain on debt extinguishment		-			(773,231	)
Change in operating assets and liabilities:
Increase (decrease) in accounts payable and accrued expenses		123,108			506,860
Increase in payables – related parties		267,484			390,629
Net cash provided by (used in) operating activities		(130,629	)		(167,146	)

Cash flows from financing activities
Proceeds from notes payable- related party		-			6,975
Proceeds from notes payable		163,599			178,000
Repayment on notes payable		(34,271	)		(15,403	)
Net cash provided by financing activities		129,328			169,572

Net increase (decrease) in cash		(1,301	)		2,426
Cash at beginning of period		1,493			171
Cash at end of period	$	192		$	2,597

Supplement Disclosures
Interest Paid		-			-
Income tax Paid		-			-

Noncash financing and investing activities
Common stock issued for conversion of Series A preferred		-		$	400,000
Interest accrued on preferred shares	$	22,068		$	22,068
Common stock issued for convertible debt		-		$	65,000
Common stock issued for accrued expenses- related parties		-		$	704,000
Series B preferred issued notes payable	$	12,500			-
Series B preferred issued for accrued expense		-		$	904,409
Series B preferred issued for accrued expense- related parties		-		$	337,992

(Unaudited)

	Six Months Ended October 31,
	2025			2024
Cash flows from operating activities:
Net loss	$	(408,226	)	$	(73,214	)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Common stock issued for service		-			10,000
(Gain) loss on derivative liability		21,467			(7,457	)
Loss on notes		29,629			10,000
Debt settlement		1,500			-
Loan origination fee		7,900			-
Gain on debt extinguishment		-			(428,065	)
Change in operating assets and liabilities:		-			-
Increase (decrease) in accounts payable and accrued expenses		63,484			382,953
Increase in payables – related parties		190,669			65,180
Net cash provided by (used in) operating activities		(93,577	)		(40,603	)
Cash flows from financing activities
Proceeds from notes payable- related party		41,803			933
Proceeds from notes payable		80,400			40,000
Repayment on notes payable		(30,056	)		(273	)
Net cash provided by financing activities		92,147			40,660
Net increase (decrease) in cash		(1,430	)		57
Cash at beginning of period		1,493			171
Cash at end of period	$	63		$	228
Supplement Disclosures
Interest Paid
Income tax Paid
Noncash financing and investing activities
Common stock issued for conversion of Series A preferred		-		$	400,000
Interest accrued on preferred shares	$	14,712		$	14,712
Series B preferred issued for conversion of notes payable	$	12,500			-
Series B preferred issued for accrued expense		-		$	789,332
Series B preferred issued for accrued expense- related parties		-		$	331,992

See notes to condensed consolidated financial statements

Table of Contents

Defense Technologies International Corp. and Subsidiary

Notes to Condensed Consolidated Financial Statements

As of ~~October~~January 31, ~~2025~~2026

(Unaudited)

NOTE - 1: BASIS OF PRESENTATION AND ORGANIZATION

Defense Technologies International Corp. (the "“Company "“) was incorporated in the State of Delaware on May 27, 1998. Effective June 15, 2016, the Company changed its name to Defense Technologies International Corp. from Canyon Gold Corp. to more fully represent the Company'’s expansion goals into the advanced technology sector.

On October 19, 2016, the Company entered into a Definitive Agreement with Controlled Capture Systems, LLC (“CCS”), representing the inventor of the technology and assets previously acquired by DTC, that included a new exclusive Patent License Agreement and Independent Contractor agreement. Under the license agreement with CCS, the Company acquired the world-wide exclusive rights and privileges to the CCS security technology, patents, products and improvements. The Company agreed to pay CCS an initial licensing fee of $25,000 and to pay ongoing royalties as defined in the Definitive Agreement. On May 30, 2018, the Company and Control Capture Systems, LLC amended their license agreement as follows (1) Royalty payments of 5% of gross sale from the license agreement will be calculated and paid quarterly with a minimum of $12,500 paid each quarter (2) All payment will be in US dollars or stock of the Company and or its subsidiary. The value of the stock will be a discount to the market of 25% of the average trading price for the 10 days prior to conversion. The number of shares received by Control Capture prior to any reverse split are anti-dilutive (3)Invoices for parts and materials will be billed ~~separate~~separately of the license fees noted above.

Effective January 12, 2017, Passive Security Scan, Inc. ("“PSSI"”) was incorporated in the state of Utah as subsidiary controlled by the Company. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company. The Company currently owns 76.28% of PSSI with 23.72% acquired by several individuals and entities. The Company’s unique technology works precisely to specifications as required by our technology and as confirmed in the market. All sales and marketing activities will be executed through PSSI.

On June 28, 2022 the Company’s common shares were reversed with each shareholder receiving one share of common stock for each 500 shares held before the reverse split. The number of shares throughout the disclosure have been retrospectively adjusted to represent the number of shares after the reverse split.

Basis of Presentation

These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. The Company’s fiscal year end is April 30.

The interim condensed consolidated financial statements have been prepared without audit in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Securities and Exchange Commission (“SEC”) Form 10-Q. They do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. Therefore, these unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended April 30, 2025 included in its Annual Report on Form 10-K filed with the SEC.

The interim condensed consolidated financial statements included herein are unaudited; however, they contain all normal recurring accruals and adjustments that, in the opinion of management, are necessary to present fairly the Company’s consolidated financial position as of ~~October~~January 31, ~~2025~~2026, the consolidated results of its operations and its consolidated cash flows for the ~~six~~three and nine months ended ~~October~~January 31, ~~2025~~2026 and ~~2024~~2025. The results of operations for any interim period are not necessarily indicative of the results to be expected for the full fiscal year.

Consolidation and Non-Controlling Interest

These consolidated financial statements include the accounts of the Company, and its majority-owned subsidiary, PSSI, from its formation on January 12, 2017 to date. All inter-company transactions and balances have been eliminated. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company for 17,500 shares of PSSI valued at $378,600 for 76.28% of PSSI.

Table of Contents

Consolidation and Non-Controlling Interest

Inventory

Inventories are stated at the lower of cost using the first-in, first-out (FIFO) cost method of accounting. Inventories as of ~~October~~January 31, ~~2025~~2026 consist of parts used in assembly of the units being sold plus work in progress and finished goods. As of ~~October~~January 31, ~~2025~~2026 and April 30, 2025 the value of the inventory was $7,599.

Equipment

Equipment is carried at the cost of acquisition and depreciated over the estimated useful lives of the assets. Costs associated with repair and maintenance is expensed as incurred. Costs associated with improvements which extend the life, increase the capacity or improve the efficiency of our property and equipment are capitalized and depreciated over the remaining life of the related asset. Gains and losses on dispositions of equipment are reflected in operations. Depreciation is provided using the straight-line method over the estimated useful lives of the assets.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Impairment of Long-Lived Assets

We continually monitor events and changes in circumstances that could indicate carrying amounts of long-lived assets may not be recoverable. When such events or changes in circumstances are present, we assess the recoverability of long-lived assets by determining whether the carrying value of such assets will be recovered through undiscounted expected future cash flows. If the total of the future cash flows is less than the carrying amount of those assets, we recognize an impairment loss based on the excess of the carrying amount over the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or the fair value less costs to sell.

Net Income (Loss) per Common Share

Basic net income or loss per common share is calculated by dividing the Company’s net income or loss by the weighted average number of common shares outstanding during the period. Diluted net income or loss per common share is calculated by dividing the Company’s net income or loss by sum of the weighted average number of common shares outstanding and the dilutive potential common share equivalents then outstanding. Potential dilutive common share equivalents consist of shares issuable upon exercise of outstanding stock options and warrants, using the treasury stock method and the average market price per share during the period, and conversion of convertible debt, using the if converted method. As of ~~October~~January 31, ~~2025~~2026, the Company had potential shares issuable under convertible preferred shares and convertible debt for a total of 3437,~~344~~353,~~987~~890.

Segment Reporting

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU) No 2023-07 Segment Reporting This amendment is an update on all public entities that are required to report segment information in accordance with Topic 280 Segment Reporting. The amendment improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The ASU on an annual and interim bases requires disclosure of significant revenue and expenses on segmented basis. In addition to the measurements that are most consistent with the measurement principles under generally accepted accounting principles (GAAP), a public entity is not precluded from reporting additional measures of a segment’s profit or loss that are used by the CODM in assessing segment performance and deciding how to allocate resources. The Company operates as a single reportable revenue segment under ASC 280, consistent with the management approach. The Company segments expenses into Research and development, consulting and general and administrative expense. The Chief Operating Decision Maker (CODM), identified as the Chief Executive Officer, reviews financial performance and allocates resources on a consolidated basis. The Company’s operations are centered around the sale of its passive portals which represents the sole source of revenue.

Table of Contents

Segment Reporting

Although there are several other new accounting pronouncements issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does not believe any of these accounting pronouncements has had or will have a material impact on its consolidated financial position or results of operations.

NOTE - 2: GOING CONCERN

These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America applicable to a going concern. Through ~~October~~January 31, ~~2025~~2026, the Company had no revenues, has accumulated deficit of $18,~~439~~628,~~015~~736 and a working capital deficit of $2,~~469~~661,~~352~~157 and expects to incur further losses in the development of its business. The Company has not yet established an ongoing source of revenue sufficient to cover operating costs, which raises substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustment that might result from the outcome of this uncertainty.

Management plans to continue to provide for the Company'’s capital needs during the year ending April 30, 2026 by issuing debt and equity securities and by the continued support of its related parties. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts ~~and~~or classification of liabilities that might be necessary should the Company be unable to continue in existence.

NOTE -– 3: ~~RELATED PARTY TRANSACTIONS~~INVESTMENTS

Effective January 12, 2017, Passive Security Scan, Inc. (“PSSI”) was incorporated in the state of Utah as subsidiary controlled by the Company. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company for 17,500 shares of PSSI valued at $378,600 for 76.28% of PSSI. The balance of PSSI was acquired by four individuals and entities. The Company plans to continue the development of the technology and conduct all sales and marketing activities in PSSI. The investment was impaired as of April 30, 2019.

Table of Contents

NOTE -4: RELATED PARTY TRANSACTIONS

Management and administrative services are currently compensated as per a Service Agreement between the Company and its Chief Executive Officer and Director executed on April 25, 2016 and a Service Agreement with the subsidiary PSSI executed on January 12, 2017, a Service Agreement between the Company and a Director executed on May 20, 2016, and an Administration Agreement with a related party executed on March 15, 2011 and renewed on May 1, 2017 and renewed in August 21, 2020 plus the assumption of a Service Agreement with the subsidiary PSSI assumed on January 12, 2017 and renewed on August 21, 2020, whereby the fee is based on services provided and invoiced by the related parties on a monthly basis and the fees are paid in cash when possible or with common stock. The Company also, from time to time, has some of its expenses paid by related parties with the intent to repay. These types of transactions, when incurred, result in payables to related parties in the Company’s consolidated financial statements as a necessary part of funding the Company’s operations.

On May 1, 2022, the Company entered into a loan agreement with EMAC Handels AG for short term loans up to $100,000. The loans bear interest at 6% per annum. As of ~~October~~January 31, ~~2025~~2026, the outstanding balance on the loan ~~agreement~~agreements was $~~117~~116,~~708~~168 plus accrued interest.

~~During~~Beginning ~~the~~November ~~six months~~20, ~~ending October 31~~2023,~~2024~~ the Company ~~issued~~received ~~10,686,860~~advancements ~~shares~~from ofEMAC ~~common stock~~Hamdels ~~for~~in ~~the~~PSSI. The ~~conversion~~balance ofat 1January 31,~~068,686~~ of2026 ~~Series~~is ~~B preferred shares.~~$36,186

During the ~~six~~nine months ending ~~October~~January 31,~~2024~~ ~~the~~2025 the Company issued 10,~~000~~686,~~000~~860 ~~with~~shares ~~an aggregate value~~ of ~~$695,000~~common stock for the ~~payment~~conversion of ~~related~~1,068,686 ~~party debt. As part~~ of ~~the~~Series ~~conversion~~B ~~the~~preferred ~~Company recognized a loss on notes of $295,000~~shares.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued 7910,~~991~~000,000 ~~shares of series B preferred~~ with aan aggregate value of $~~329~~695,~~930~~000 tofor 2the ~~related~~payment ~~parties~~of ~~for~~related ~~accrued~~party ~~liabilities~~debt. ~~The~~As ~~transaction~~part ~~resulted~~of inthe aconversion ~~gain~~the onCompany ~~debt~~recognized ~~settlement~~a ~~which~~loss ~~was~~on ~~recorded~~notes asof ~~paid in capital~~$295,000.

AsDuring ofthe ~~October~~nine months ended January 31, 2025, an ~~and~~officer ~~April~~of ~~30,~~the ~~2025,~~Company advanced the Company ~~had~~$9,460. The ~~payable~~advance ~~balances~~bears ~~due~~no tointerest ~~related~~and ~~parties~~is ~~totaling~~due ~~$937,877~~on ~~and~~August ~~$747~~28,~~208,~~ ~~respectively~~2025.

~~NOTE~~During -the 4:nine ~~NOTES~~months ~~PAYABLE~~ended January 31, 2026 the Company issued notes to Eric Forrest of $7,750 for total notes outstanding of $17,210.

On November 13, 2025 Merril Moses advanced the Company $1,000.

As of January 31, 2026, the Company has an outstanding note payable to Star Anchor for $19,030 plus accrued interest.

During the nine months ending January 31, 2025 the Company issued 94,991 shares of series B preferred with a value of $367,431 to 2 related parties for accrued liabilities. The transaction resulted in a gain on debt settlement which was recorded as paid in capital.

As of January 31, 2026 and April 30, 2025, the Company had payable balances due to related parties totaling $1,014,693 and $747,208, respectively.

NOTE – 5: NOTES PAYABLE

On March 5, 2018, the Company subsidiary PSSI entered into a note agreement with Premium Marketing Associates, LLC for $25,000. The funds were designated for use in a marketing agreement with the Edward Fitzgerald Group for raising funds for PSSI. The note was to be repaid from investment fund generated by the Fitzgerald group plus 15% of the funds generated are paid to the investor.

9On ~~Table~~July 18, 2018, the Company entered into a promissory note of ~~Contents~~$114,226.26 with interest rate of 8% per annum with Haynie & Company the Company’s former auditors. Under the terms of the agreement commencing August 15, 2018 the Company is to pay Haynie $5,000 per month. In addition, the Company shall pay the noteholder 20% of any funding event of private or public equity. On July 11, 2022, the Company negotiated a settlement of $37,500 with an initial payment of $30,000 and the balance due of $7,500 thirty days after the initial payment. As of January 31, 2026 the note had not been paid leaving the balance due on the note of $20,042.

On ~~July~~May 181, ~~2018~~2022, the Company entered into a ~~promissory~~loan ~~note~~agreement ~~of $114,226.26~~ with ~~interest~~EMAC ~~rate~~Handels ofAG for 8%short ~~per~~term ~~annum~~loans ~~with~~up ~~Haynie & Company the Company’s former auditors. Under the terms of the agreement commencing August 15, 2018 the Company is~~ to ~~pay Haynie~~ $5100,000 ~~per month~~. The Inloans ~~addition,~~bear ~~the~~interest ~~Company~~at ~~shall pay the noteholder 20~~6% ofper ~~any funding event of private or public equity~~annum. ~~On July 11, 2022, the Company negotiated a settlement of $37,500 with an initial payment of $30,000 and the balance due of~~ ~~$7,500 thirty days after the initial payment.~~ As of ~~October~~January 31, ~~2025 the $7~~2026,~~500~~ ~~had not been paid leaving~~ the outstanding balance ~~due~~ on the ~~note~~loan ofagreement was $20116,~~042~~168 plus accrued interest.

OnBeginning ~~May~~November 120, ~~2022~~2023, the Company ~~entered~~received ~~into~~advancements afrom ~~loan agreement with~~ EMAC ~~Handels AG for short term loans up to $100,000~~Hamdels. The ~~loans~~balance ~~bear interest~~ at 6%January ~~per annum. As of October~~ 31, ~~2025,~~2026 ~~the~~is ~~outstanding balance on the loan agreement was~~ $~~117~~36,~~708 plus accrued interest~~186.

On July 1110, 2024 the Company issued a promissory note for $50,000, The note ~~matures~~matured in one year from issuance and bears interest at 10% per annum. The note has an initial discount of $10,000 and is not convertible.

On December 13, 2024, the Company issued a promissory note to Mayday Management Inc for $12,500. plus interest and cost of $845. The ~~Note~~note ~~matured~~was due on ~~July~~February 1110, 2025. On May 25, 2025 the ~~Company~~note ~~issued~~was converted to 100,000 ~~shares~~share of series B preferred ~~in payment of the note~~stock.

On ~~May~~December 613, ~~2025~~2024 the Company issued a promissory note for $12,000. The note matures July 11, 2025. The note has an initial discount of $2,000 and is not convertible.

On ~~May~~December 2726, ~~2025~~ 2024 the Company issued a promissory note for $1250,000. The note ~~matures~~matured on July 11, 2025. The note has an initial discount of $210,000 and is not convertible.

On June 26, 2025 the Company issued a promissory note for $9,400. The note matures July 11, 2025. The note has an initial discount of $1,900 and is not convertible.

On July 29, 2025 the Company issued a promissory note for $12,000. The note matures September, 2025. The note has an initial discount of $2,000 and is not convertible.

On August 12, 2025 the Company issued a promissory note for $18,000. The note matures September 10, 2025. The note has an initial discount of $3,000 and is not convertible.

On September 16, 2025, the Company issued a promissory note for $12,000. The note matures September 10, 2025. The note has an initial discount of $2,000 and is not convertible.

The Company periodically receives advances from RAB Investments. The advances are payable on demand and bear no interest. As of October 31, 2025, the outstanding balance due from the Company was $10,230.

As of October 31, 2025, and April 30, 2025 the outstanding balances of notes payable were $541,288 and $476,312, respectively.

NOTE - 5: CONVERTIBLE DEBT

On March 10, 2016, the Company entered into a convertible promissory note for $17,000 with ACM Services GmbH, which bears interest at an annual rate of 6% and is convertible into shares of the Company’s common stock at $0.05 per share. The Company recorded a debt discount and a beneficial conversion feature of $17,000 at the inception of the note. As of October 31, 2025 the balance of the notes was $7,000 plus interest.

On August 3, 2016, the Company entered into a convertible promissory note with an institutional investor for $25,000, which bears interest at an annual rate of 12% and matures on February 4, 2017. The note holder has the right, after a period of 180 days of the note, to convert the note and accrued interest into shares of the common stock of the Company at a discounted price per share equal to 50% to 65% of the market price of the Company’s common stock, depending upon the stock’s liquidity as determined by the note holder’s broker. On March 20, 2017, the lender converted $12,500 principal into 1,000,000 shares of the Company’s common stock. As of October 31, 2025, the note has a balance of $12,500 plus interest and is currently in default.

Table of Contents

On ~~October~~January 47, ~~2018,~~ 2025 the Company ~~entered into an agreement with RAB Investments AG to consolidate all RAB outstanding notes~~ issued ~~by the Company prior to October 31, 2018. Under the terms of the agreement the Company agreed to accept~~ a ~~six~~promissory ~~percent interest to be calculated on all the notes since their inception. The agreement resulted in a new~~ note for $~~330~~50,~~626~~000. ~~which~~The ~~included~~note ~~the~~matures ~~additional~~July ~~interest~~11, ~~and retired the original notes~~2025. The note ishas ~~convertible~~an ~~into~~initial ~~common~~discount ~~stock~~ of ~~the Company at~~ $~~25 per share. As of October 31~~10,000 ~~2025, the~~and ~~outstanding~~is ~~balance~~not ~~of the note were $197,085 plus interest~~convertible.

~~During~~On ~~the~~January ~~six months ending October 31~~21, ~~2024~~2025 the Company issued ~~10,000,000 shares of common stock with~~ a ~~value~~promissory ofnote of $~~695~~43,~~000~~500. ~~for~~The ~~the~~note ~~payment~~matured ofon ~~related~~July ~~party~~11, ~~debt~~2025. AsThe ~~part~~note ofhad ~~the~~an ~~conversion~~initial ~~the~~discount ~~Company recognized a loss on notes~~ of $~~295~~8,~~000~~500.

AsOn ofFebruary ~~October 31~~12, 2025, the ~~and~~Company ~~April~~issued ~~30,~~a ~~2025~~promissory note for $105,000. ~~the~~The ~~convertible~~note ~~debt~~matures ~~outstanding~~July 11, ~~net~~2025. ofThe note has an initial discount, ~~was~~of $~~215~~15,~~392~~000 and ~~$185,762,~~is ~~respectively.~~not convertible,

~~NOTE~~On -February 6:18, ~~FAIR~~2025 the ~~VALUE~~Company ~~MEASUREMENTS~~issued ~~AND~~a ~~DERIVATIVE~~promissory ~~LIABILITIES~~note for $105,000. The note matures July 11, 2025. The note has an initial discount of $15,000 and is not convertible

On March 11, 2025 the Company issued a promissory note for $25,000. The note matures July 11, 2025. The note has an initial discount of $5,000 and is not convertible.

During the nine months ended January 31, 2025, an officer of the Company advanced the Company $9,460. The advance bears no interest and is due on August 28, 2025.

Beginning November 20, 2023, the Company received advancements from EMAC Hamdels in PSSI. The balance at January 31, 2026 is $36,186

On May 6, 2025 the Company issued a promissory note for $12,000. The note matured July 11, 2025. The note has an initial discount of $2,000 and is not convertible.

On May 27, 2025 the Company issued a promissory note for $12,000. The note matured July 11, 2025. The note has an initial discount of $2,000 and is not convertible.

On June 26, 2025 the Company issued a promissory note for $9,400. The note matured July 11, 2025. The note has an initial discount of $1,900 and is not convertible.

On July, 29, 2025 the Company issued a promissory note for $12,000. The note matured September 10, 2025. The note has an initial discount of $2,000 and is not convertible.

On August 12, 2025 the Company issued a promissory note for $18,000. The note matured September 10, 2025. The note has an initial discount of $3,000 and is not convertible.

On September 16, 2025, the Company issued a promissory note for $12,000. The note matured September 10, 2025. The note has an initial discount of $3,000 and is not convertible.

On November 6, 2025 the Company issue a note for $12,000. The note matures on December 15, 2025 . The note has an original discount of $2,000.

On December 12, 2025 the Company issued a note in the amount of $7,750 to Eric Forrest. The note bears an interest rate of 5% and is due on March 15, 2026.

On December 12, 2025 the Company issued a note in the amount of $6,000 with a discount of 10% The note matured on December 30, 2025.

On January 29, 2026, the Company issued a promissory note for $6,000. The note matures March 30, 2026. The note has an initial discount of $1,000 and is not convertible.

During the nine months period ending January 31, 2026, Mayday Management advanced the Company $5,000.

The Company periodically receives advances from RAB Investments. The advances are payable on demand and bear no interest. As of January 31, 2026 the outstanding balance due from the Company was $10,230.

As of January 31, 2026, and April 30, 2025 the outstanding balances of notes payable were $565,288 and $476,312, respectively.

NOTE – 6: CONVERTIBLE DEBT

On March 10, 2016, the Company entered into a convertible promissory note for $17,000 with ACM Services GmbH, which bears interest at an annual rate of 6% and is convertible into shares of the Company’s common stock at $0.05 per share. The Company recorded a debt discount and a beneficial conversion feature of $17,000 at the inception of the note. As of January 31, 2026 the balance of the notes was $7,000 plus interest.

On August 3, 2016, the Company entered into a convertible promissory note with an institutional investor for $25,000, which bears interest at an annual rate of 12% and matures on February 4, 2017. The note holder has the right, after a period of 180 days of the note, to convert the note and accrued interest into shares of the common stock of the Company at a discounted price per share equal to 50% to 65% of the market price of the Company’s common stock, depending upon the stock’s liquidity as determined by the note holder’s broker. On March 20, 2017, the lender converted $12,500 principal into 1,000,000 shares of the Company’s common stock. As of January 31, 2026, the note has a balance of $12,500 plus interest and is currently in default.

Table of Contents

On October 4, 2018, the Company entered into an agreement with RAB Investments AG to consolidate all RAB outstanding notes issued by the Company prior to October 31, 2018. Under the terms of the agreement the Company agreed to accept a six percent interest to be calculated on all the notes since their inception. The agreement resulted in a new note for $330,626 which included the additional interest and retired the original notes. As of January 31, 2026, the outstanding balance of the note were $197,085 plus interest.

During the nine months ending January 31, 2025 the Company issued 10,000,000 with a value of $695,000 for the payment of related party debt. As part of the conversion the Company recognized a loss on notes of $295,000.

As of January 31, 2026, and April 30, 2025, the convertible debt outstanding, net of discount, was $215,392 and $185,762

NOTE – 7: FAIR VALUE MEASUREMENTS AND DERIVATIVE LIABILITIES

As defined in (Financial Accounting Standards Board ASC 820), fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilized the market data of similar entities in its industry or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observability of those inputs. FASB ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement).

The three levels of the fair value hierarchy are as follows:

Level 1 –	Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.

Level 2 -	Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.

Level 3 –	Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value.

As12 ofTable ~~October 31, 2025, the Company believes the amounts reported for cash, payables, accrued liabilities and amounts due to related parties approximate their fair values due to the nature or duration~~ of ~~these instruments.~~ Contents

~~The~~As ~~following~~of January ~~table~~31, ~~represents~~2026, the ~~change~~Company inbelieves the ~~fair~~amounts ~~value~~reported offor ~~the~~cash, ~~derivative~~payables, accrued liabilities ~~during~~and amounts due to related parties approximate their fair values due to the ~~six~~nature ~~months~~or ~~ended~~duration ~~October~~of ~~31,~~these ~~2025:~~instruments.

	Level 1		Level 2		Level 3
Balance at April 30, 2025	$	-	$	-	$	31,866
Change in fair value of derivative liability		-		-		21,467
Balance at October 31, 2025	$	-	$	-	$	53,533

The following table represents the change in the fair value of the derivative liabilities during the nine months ended January 31, 2026:

11 Table of Contents

	Level 1		Level 2		Level 3
Balance at April 30, 2025	$	-	$	-	$	31,866
Change in fair value of derivative liability		-		-		36,779

Balance at January 31, 2026	$	-	$	-	$	68,645

The estimated fair value of the derivative liabilities at January ~~October~~ 31, ~~2025~~2026 was calculated using the Binomial Lattice pricing model with the following assumptions:

Risk-free interest rate	~~4.50~~	4.50
Expected life in years	~~0.10~~	0.10
Dividend yield	0%	0%
Expected volatility	~~254.00%~~	804.00%

NOTE -– 78: EQUITY

Common Stock

On April 26, 2022, the Company filed an amendment to the Articles of Incorporation increasing the authorized shares of common stock to 600,000,000 with a par value of $0.0001 and the total number of preferred shares at 20,000,000, par value $0.0001.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued 10,686,860 shares of common stock for the conversion of 1,068,686 of Series B preferred shares.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued ~~100~~850,000 shares of common stock with a value of $1055,000 for the payment of consulting fees.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~ 2025 the Company issued ~~431~~1,~~181~~631,143 shares of common stock for the conversion of 26 7 shares of series D preferred shares.

During ~~the~~nine ~~six~~ months ~~ending~~ended ~~October~~January 31, ~~2024~~2025, the Company issued 101,~~000~~250,000 shares of common stock with ana ~~aggregate~~ value of $~~695~~62,~~000~~500 for the ~~payment~~conversion of ~~related~~convertible ~~party~~ debt. ~~As part of the conversion the Company recognized a loss on notes of $295,000.~~

During the ~~six~~nine months ~~period~~ending ~~ended~~January ~~October~~ 31, 2025, the Company issued 310,~~383~~000,~~876~~000 shares ~~of common stock~~ with aan aggregate value of $33695,~~839~~000 for the ~~conversion~~payment of 29related ~~preferred~~party Ddebt. ~~shares~~As part of the conversion the Company recognized a loss on notes of $295,000.

During the nine months period ended January 31, 2026, the Company issued 3,383,876 shares of common stock with a value of $33,839 for the conversion of 29 preferred D shares.

Table of Contents

Preferred Stock

The Company has 20,000,000 shares of $0.0001 par value preferred stock authorized and has designated a Series A preferred stock, a Series B preferred stock, a series C preferred stock and a series D preferred stock. The Company has authorized 5,000,000 series A and B shares each plus 1,500,000 each of series C and D preferred shares Each share of the Series A preferred stock is convertible into ten common shares and carries voting rights on the basis of 100 votes per share. Each share of the Series B preferred stock is convertible into ten common shares and carries no voting rights. Each of the Series C preferred shares are non-voting and are convertible to common stock as a “Blank Check” designation with terms and conditions as set by the board of directors. Each of the series D preferred shares are non-voting and may be converted into common shares as a Blank Check” designation with the terms and conditions as set forth by the board of directors

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued 10,686,860 shares of common stock for the conversion of 1,068,686 of Series B preferred shares.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024 the~~2025 the Company issued ~~191~~1,~~314~~631,143 shares of ~~series~~common ~~B preferred shares~~stock ~~to settle $789,332~~ for ~~accrued~~the ~~payables.~~conversion ~~The result~~ of ~~this~~26 ~~issuance~~shares ~~was~~of aseries ~~gain~~D onpreferred ~~debt of approximately $723,065~~shares.

During the ~~six~~nine months ending ~~October~~January 31, ~~2024~~2025 the Company issued 79213,~~991~~314 shares of series B ~~for~~preferred ~~settling~~shares to settle $~~329~~843,~~930~~831 of for accrued payables. ~~due~~The toresult ~~related~~of ~~parties~~this issuance was a gain on debt of approximately $723,065.

During the ~~six~~nine months ~~period~~ending ~~ended~~January ~~October~~ 31, 2025, the Company issued 394,~~383,876~~991 shares of ~~common~~series ~~stock~~B ~~with~~for asettling ~~value of~~ $33367,~~839~~431 ~~for~~of accrued ~~the~~payables ~~conversion~~due ofto 292 ~~preferred~~related ~~D shares~~parties.

12During ~~Table~~the nine months period ended January 31, 2026, the Company issued 3,383,876 shares of ~~Contents~~common stock with a value of $33,839 for the conversion of 29 preferred D shares.

As of ~~October~~January 31, ~~2025~~2026, the Company has 3,~~736~~735,~~120~~920 shares of preferred stock consisting of; 2,535,135 Series A shares, 1,200,254 Series B shares and 531 Series D preferred share issued and outstanding. The conversion price for the 531 series D shares issued is $0.50 or 80% of the lowest trading price 20 days prior to conversion.,

NOTE -– 89: COMMITMENTS AND CONTINGENCIES

The Company has the following material commitments as of ~~October~~ January 31, ~~2025~~2026:

a) Administration Agreement with EMAC Handel’s AG, renewed effective May 1, 2017 for a period of three years and amended May 1, 2021. Monthly fee for administration services of $7,500, office rent of $250 and office supplies of $125. Extraordinary expenses are invoiced by EMAC on a quarterly basis. The fee may be paid in cash ~~and or with common stock. b) Service Agreement signed April 25~~, 2016 with Merrill W. Moses, President, Director and CEO, for services of $7,500 per month beginning May 2016 and the issuance of 233 restricted common shares of the Company. The fees may be paid in cash and or with common stock. c) Administration and Management Agreement of PSSI signed January 12, 2017 with EMAC Handel Investments AG, for general fees of $7,500 per month, office rent of $250 and telephone of $125 beginning January 2017 and amended May 1, 2021, the issuance of 2,000 common shares of PSSI and a 12% royalty calculated on defines sales revenues payable within 10 days after the monthly sales. d) Service Agreement of PSSI signed January 12, 2017 with Merrill W. Moses, President, Director and CEO, for services of $2,500 per month beginning February 2017 and the issuance of 333 common shares of PSSI.

Service Agreement signed April 25, 2016 with Merrill W. Moses, President, Director and CEO, for services of $7,500 per month beginning May 2016 and the issuance of 233 restricted common shares of the Company. The fees may be paid in cash or with common stock.

Administration and Management Agreement of PSSI signed January 12, 2017 with EMAC Handel Investments AG, for general fees of $7,500 per month, office rent of $250 and telephone of $125 beginning January 2017 and amended May 1, 2021, the issuance of 2,000 common shares of PSSI and a 12% royalty calculated on defines sales revenues payable within 10 days after the monthly sales.

Service Agreement of PSSI signed January 12, 2017 with Merrill W. Moses, President, Director and CEO, for services of $2,500 per month beginning February 2017 and the issuance of 333 common shares of PSSI.

Table of Contents

On May 30, 2018, the Company and Control Capture Systems, LLC amended their license agreement as follows.

· Royalty payments of 5% of gross sale from the license agreement will be calculated and paid quarterly with a minimum of $12,500 paid each quarter. · All payment will be in US dollars or stock of the Company and or its subsidiary. The value of the stock will be a discount to market of 25% of the average trading price for the 10 days prior to conversion. The number of shares received by Control Capture prior to any reverse split are anti-dilutive. · Invoices for parts and materials will be billed ~~separate~~separately of the license fees noted above.

NOTE ~~- 9~~ 10: SUBSEQUENT EVENTS

OnThe Company has evaluated subsequent events to determine events occurring after January 2931, 2026 through the ~~Company~~filing ~~issued~~of athis ~~note~~report ~~for~~that ~~$6,000. The~~would ~~note~~have ~~matures~~a material impact on ~~March~~the ~~30,~~Company’s ~~2026.~~financial ~~The~~results ~~note~~or ~~has~~require andisclosure ~~original~~other ~~discount~~than ofthose ~~$1,000~~noted above.

~~The~~15 ~~Company~~Table ~~has evaluated subsequent events to determine events occurring after October 31, 2025 through the filing~~ of ~~this report that would have a material impact on the Company’s financial results or require disclosure other than those noted above.~~Contents

13Item ~~Table~~2: Management’s Discussion and Analysis of ~~Contents~~Financial Condition and Results of Operations

Item 2: Management's Discussion and Analysis of Financial Condition and Results of Operations

Overview

The following information should be read in conjunction with the condensed consolidated financial statements and notes thereto appearing elsewhere in this Form 10-Q.

On May 30, 2018, the Company and Control Capture Systems, LLC amended their license agreement as follows (1) Royalty payments of 5% of gross sale from the license agreement will be calculated and paid quarterly with a minimum of $12,500 paid each quarter (2) All payment will be in US dollars or stock of the Company and or its subsidiary. The value of the stock will be a discount to market of 25% of the average trading price for the 10 days prior to conversion. The number of shares received by Control Capture prior to any reverse split are anti-dilutive.

Effective January 12, 2017, Passive Security Scan, Inc. ("“PSSI"”) was incorporated in the state of Utah as subsidiary controlled by the Company. The Company transferred to PSSI its exclusive world-wide license to the defense, detection and protection security products previously acquired by the Company. The Company owns 79.8% of PSSI with 20.2% acquired by several individuals and entities. The Company plans to continue the development of the technology. All sales and marketing activities are through PSSI.

The extent to which the COVID-19 pandemic may directly or indirectly impact our business, financial condition, and results of operations is highly uncertain and subject to change. We considered the potential impact of the COVID-19 pandemic on our estimates and assumptions and there was not a material impact to our consolidated financial statements as of and for the three months ended July 31, 2024.

The Company’s security products are licensed from CCS and developed by the company designed for personal and collateral protection. Products derived from this technology are intended to provide passive security scanning units for either walk-through or hand-held use to improve security for schools and other public facilities. Passive Portal units use electromagnets and do not emit anything (such as x-rays) through the subject. We have also completed a prototype with optional “Digital Imaging,” which will give the user of the scanner the ability to recall the entire traffic passing through the scanner at any time thereafter.

As of May 19, 2020, the Company added an IR Camera for detection of elevated body temperatures and is presently offering these products:

	·	PASSIVE PORTAL – Screens for Weapons only;
	·	PASSIVE PORTAL with EBT – Screens for Weapons and elevated body temperature;
	·	EBT Station – Screens for elevated body temperature only.

Table of Contents

Forward Looking and Cautionary Statements

This report contains forward-looking statements relating to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar terms, variations of such terms or the negative of such terms. These statements are only predictions and involve known and unknown risks, uncertainties and other factors. Although forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment, actual results could differ materially from those anticipated in such statements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

14 Table of Contents

Results of Operations

During the ~~three~~nine ~~and six~~ months ended ~~October~~January 31, ~~2025 and 2024~~2026, the Company did not receive any revenue.

Our operating expenses for the three and ~~six~~nine months ended ~~October~~January 31, ~~2025~~2026, were $~~142~~143,~~182~~753 and $~~329~~473,~~412~~164 compared to $~~366~~316,~~065~~803 and $~~529~~851,~~582~~750 for the same periods in ~~2024~~2025. The variance was due primarily to lower consulting costs, which were $8075,~~000~~250 and $~~180~~255,250 compared to $~~219~~93,~~292~~200 and $~~336~~429,~~792~~992 for the same periods in ~~2024;~~2025 along with lower general and administrative costs of $6268,~~182~~503 and $~~149~~217,~~162~~914 compared to $~~146~~223,~~773~~603 and $~~192~~421,~~790~~758 in the same periods in ~~2024~~2025.

Interest expenses incurred in the three and ~~six~~nine month periods ended ~~October~~January 31, ~~2025~~2026, were $628,~~253~~740 and $1342,~~318~~058 compared to $76,~~096~~408 and $1430,~~154~~562 for the same periods in ~~2024~~2025. A loan origination fee of $51,000 and $4243,529 was incurred during the three and ~~six~~nine months ended ~~October~~January 31, ~~2025~~2026, compared to $515,000 ~~during~~and ~~the six months in 2024, along with a loss on notes of~~ $540,~~000~~500 ~~being incurred~~ during the ~~period~~three and nine months in ~~2024~~2025. The Company had a gain on debt settlement of $~~723~~50,~~065~~166 and $773,231 in the three and ~~six~~nine months periods in ~~2024~~2025 along with a loss on accounts payable of $250,000 for the ~~six~~nine months period in ~~2024~~2025.

Change in derivative liability resulted in a loss of $1615,~~359~~312 and $2136,~~467~~779 for the three and ~~six~~nine months period ended ~~October~~January 31, ~~2025~~2026, compared to a ~~loss~~gain of $~~709~~5,633 ~~for the three months period~~ and ~~gain of~~ $713,~~457~~090 ~~during~~for the ~~six~~three ~~months~~and ~~period~~nine ~~for~~months ~~the same~~ period in ~~2024.~~ 2025 We estimate the fair value of the derivative for the conversion feature of our convertible notes payable using the American Binominal Lattice pricing model at the inception of the debt, at the date of conversions to equity, cash payments and at reporting date, recording a derivative liability, debt discount and a gain or loss on change in derivative liability as applicable. These estimates are based on multiple inputs, including the market price of our stock, interest rates, our stock price volatility, and variable conversion prices based on market prices as defined in the respective loan agreements. These inputs are subject to significant changes from period to period; therefore, the estimated fair value of the derivative liability will fluctuate from period to period, and the fluctuation may be material.

Total other income and expense for the three and ~~six~~nine month periods ended ~~October~~January 31, ~~2025~~2026 was a loss of $2948,~~112~~052 and $78126,~~814~~866, compared to ~~other~~a ~~income~~gain of $~~394~~49,~~195~~391 and ~~other loss of~~ $73505,~~214~~759 for the same periods in ~~2024~~2025.

Net loss before non-controlling interest for the three and ~~six~~nine month periods ended ~~October~~January 31, ~~2025~~2026, were a net loss of $~~171~~191,~~294~~805 and $~~408~~600,~~226~~030 compared to a net ~~income~~loss of $~~394~~267,~~195~~412 and ~~net loss of~~ $73345,~~214~~991 for the same periods in ~~2024~~2025. After adjusting for our consolidated subsidiary, net loss for the three and ~~six-~~nine month ~~period~~periods ended ~~October~~ January 31, ~~2025~~2026 was a net loss of $~~159~~182,~~942~~365 and $~~382~~564,~~106~~471 compared to a net ~~income~~loss of $~~398~~262,~~527~~046 and ~~net loss of~~ $62330,~~712~~124 for the same periods in ~~2024~~2025.

Table of Contents

Liquidity and Capital Resources

At ~~October~~January 31, ~~2025~~2026 the Company had total current assets of $7,~~662~~791 and total current liabilities of $2,~~477~~668,~~014~~948 resulting in a working capital deficit of $2,~~469~~661,~~352~~157. Included in our current liabilities and working capital deficit at ~~October~~January 31, ~~2025~~2026 are derivative liabilities totaling $5368,~~333~~645 related to the conversion features of certain of our convertible notes payable, convertible notes of $215,392, net of discount, payables due related parties of $~~937~~1,~~877~~014,693, accounts payable and accrued expense of $~~197~~216,~~596~~670, accrued interest and fees payable of $~~233~~261,~~491~~541, notes payable related parties $~~183~~199,~~662~~844 and notes payables of $~~541~~562,288. We anticipate that in the short term, operating funds will continue to be provided by related parties and other lenders.

During the ~~six~~nine months period ended ~~October~~January 31, ~~2025~~2026, net cash used in operating activities was $93130,~~577~~629 compared to cash used of $40167,~~603~~146 in the same period in ~~2024~~2025. Net cash used in the ~~six~~nine months period in ~~2025~~2026 consisted of net loss of $~~408~~600,~~226~~030, change in payables to related parties of $~~190~~267,~~669~~484, increase in accounts payable of $63123,~~484~~108, along with loan origination fee and loss on notes of $2910,~~629~~900, plus loss on ~~derivative~~debt settlement of $211,~~467~~500, loss on notes of $29,~~629,~~630 ~~debt~~and ~~settlement~~change ofin ~~$1,500~~fair ~~and~~value ~~Loan~~of ~~origination~~the ~~fees~~derivative liability of $736,~~900~~779.

During the ~~six~~nine months ended ~~October~~ January 31, ~~2025~~2026 net cash provided by financing activities was $92129,~~147~~328 consisting of proceeds from notes payable ~~related parties~~ of ~~41,803 and notes payable of~~ $80163,~~400~~599 offset by repayment of notes payable of $3034,~~056~~271. We have had no revenue for the nine months periods ending January 31, 2026 and 2025 and have paid expenses and costs with proceeds from the issuance of securities as well as by loans from investor, stockholders and other related parties.

Our immediate goal is to provide funding for the completion of the production of the Offender Alert Passive Scan licensed from CCS. The Offender Alert Passive Scan is an advanced passive scanning system for detecting and identifying concealed threats.

We believe a related party and other lenders will provide sufficient funds to carry on general operations in the near term and fund DTC’s production and sales. We expect to raise additional funds from the sale of securities, stockholder loans and convertible debt. However, we may not be successful in our efforts to obtain financing to carry out our business plan.

15 Table of Contents

See the notes to our condensed consolidated financial statements for a discussion of recently issued accounting pronouncements that we have either implemented or that may have a material future impact on our financial position or results of operations.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

This item is not required for a smaller reporting company.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures. As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our management including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) (“Exchange Act”). Based on this evaluation, the principal executive officer and principal financial officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were not effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in applicable rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, in a manner that allows timely decisions regarding required disclosures.

We operate with a limited number of accounting and financial personnel. Although we retain the services of an experienced certified public accountant, we have been unable to implement proper segregation of duties over certain accounting and financial reporting processes, including timely and proper documentation of material transactions and agreements. We believe these control deficiencies represent material weaknesses in internal control over financial reporting.

Despite the material weaknesses in financial reporting noted above, we believe that our consolidated financial statements included in this report fairly present our financial position, results of operations and cash flows as of and for the periods presented in all material respects.

Changes in Internal Control over Financial Reporting. There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

1618 Table of Contents

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

There are no material ~~pending~~ legal proceedings to which we are a party or to which any of our property is subject and, to the best of our knowledge, no such actions against us are contemplated or threatened.

Item 1A. Risk Factors

This item is not required for a smaller reporting company.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

During the ~~six~~nine months period ended ~~October~~January 31, ~~2025~~2026, the Company issued 3,383,876 shares of common stock with a value of $33,839 for the conversion of 29 preferred D shares.

Item 3. Defaults Upon Senior Securities

This item is not applicable.

Item 4. Mine Safety Disclosure

This item is not applicable.

Item 5. Other Information

Not applicable

1719 Table of Contents

Item 6. Exhibits

The following exhibits are filed as part of this report:

Exhibit No.		Description of Exhibit
31.1		Section 302 Certification of Chief Executive Officer and Chief Financial Officer
32.1		Section 1350 Certification of Chief Executive Officer and Chief Financial Officer
101 INS*		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101SCH*		Inline XBRL Taxonomy Extension Schema
101 CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase
101 DEF*		Inline XBRL Taxonomy Extension Definition Linkbase
101 LAB*		Inline XBRL Taxonomy Extension Label Linkbase
101 PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

* The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Exchange Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

1820 Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DEFENSE TECHNOLOGIES INTERNATIONAL CORP.
Date: February 9, 2026	By:	/s/ Merrill W. Moses
Date: April 23, 2026	By:	/s/ Merrill W. Moses
		Merrill W. Moses
		Chief Executive Officer
		Acting Chief Financial Officer

1921

Filing Compare · DEFENSE TECHNOLOGIES INTERNATIONAL CORP.